Stroke Risk Reduction Savings Tips

Savings Tips for Stroke Risk Reduction

Get the latest updates on this condition from the GoodRx medical team.

  • Top 10 New Drugs of 2015

    November 16, 2015

    Pharmaceutical manufacturers released a number of new prescription drugs in 2015. Some of these new drugs are truly lifesavers . . . and some aren’t. Either way, pharmaceutical companies will be spending lots of money to let you know about them—you’ll be seeing them on the sides of buses and in TV commercials for quite a while.

    As a doctor, I’m always excited about improvements that help patients. Some of the drugs below can really make a difference. See More

  • Jardiance for Diabetes Reduces Deaths from Heart Disease

    September 17, 2015

    Good news! In a just-published study, Jardiance (empagliflozin) for type 2 diabetes has been shown to reduce deaths from cardiovascular disease.

    The results are impressive. Comparing Jardiance to a placebo, the study showed a 38% reduction in the risk of death from a cardiovascular cause (3.7% with Jardiance vs 5.9% with placebo). Jardiance was also shown to reduce the risk of any cardiovascular event (heart attack, stroke, or death) by 14%, and to reduce the risk of death from all causes by 32%. See More

  • Generic Aggrenox for Stroke Prevention In Pharmacies Now

    August 11, 2015

    According to the Centers for Disease Control and Prevention (CDC), strokes are a leading cause of death in the United States. Strokes are responsible for 1 in every 20 deaths or approximately 130,000 Americans every year.

    Aggrenox is used to help prevent stroke if you’ve had a previous “mini-stroke” or an actual ischemic stroke—and the generic, aspirin/extended-release dipyridamole, was just approved by the FDA on July 1, 2015! A new lower cost for a life-saving drug? This is good news. See More

  • 5 Common Medications That Can Kill

    July 13, 2015

    You probably already know that many prescriptions have side effects. Most are mild—annoying issues like nausea or sleepiness that are inconvenient at worst. Others, however, can be deadly.

    A very small number of medications are responsible for the majority of adverse side effects and hospitalizations from harmful drug reactions. How bad are these drugs? Between 2007 to 2009, almost 100,000 patients older than 65 had emergency hospitalizations for dangerous drug reactions, and almost 20,000 people die from prescription drug overdoses annually. See More

  • Is Coffee Bad for You?

    January 22, 2015

    Is drinking coffee bad for me? For a drink as popular as coffee, its physiologic effects are something you should learn about. You will be reassured I’m sure.

    The Good

    Maintaining alertness is a well-known benefit and what most of us rely on caffeine for. But what else? Every day my patients ask me if coffee is bad for their heart. In addition to caffeine coffee contains polyphenols which are dietary antioxidants. See More

  • What’s the Deal With Zetia (Ezetimibe): A Good Alternative to Statins for Preventing Heart Attack and Stroke?

    November 25, 2014

    When I read criticisms of doctors prescribing expensive medications that might not benefit patients at all, I think of Zetia (ezetimibe) as the poster child. News came out last week after the IMPROVE-IT trial that seemed to pump it up, but what we learned from this large trial may surprise you and let you down at the same time.

    1. Billions and billions of dollars have already been spent on Zetia—despite not knowing whether it has any benefit to you other than lowering LDL cholesterol a little bit.
    2.  See More
  • New Anticoagulant Med Zontivity: Now FDA Approved!

    May 19, 2014

    Zontivity (voraxapar) is a new type of anti-platelet medication for people who have had a heart attack, or who have reduced blood flow in their legs. It is used to reduce the risk of heart attack, stroke, cardiovascular death, and the need for procedures to restore blood flow to the heart. It was approved by the FDA in May 2014, and will be available from manufacturer Merck later this year.

    When will Zontivity be available?

    According to the manufacturer the anticipated availability date for this medication is the third quarter of 2014. See More

  • Move Over Warfarin – No, Really

    January 04, 2013

    Of all the new oral anticoagulants set to take over for Coumadin (warfarin) the new drug Xarelto just scored a trifecta. Remember these newer blood thinners are much more convenient than warfarin because you are spared the weekly blood tests to monitor your INR (coagulation levels).

    Xarelto (rivaroxaban) has been approved by the FDA for the treatment of deep vein thrombosis (DVT) and/or pulmonary embolism (PE), and to reduce the risk of recurrence of DVT and PE after initial treatment. See More

  • New Warnings About Pradaxa

    November 20, 2012

    The buzz around Pradaxa has deflated a bit with reports of bleeding risks. Pradaxa (dabigatran) changes the body’s clotting system and thins the blood to prevent clots from forming. Pradaxa is exciting because it is a good alternative to warfarin in patients with atrial fibrillation. Warfarin (Coumadin), unlike Pradaxa, requires serial blood tests to check INR. Pradaxa is much more convenient than warfarin, but is it riskier?

    Pradaxa works. See More

  • Plavix Now Available as Generic Clopdigrel: Bring on the Savings!

    June 01, 2012

    A staggering 2.5 million Plavix prescriptions are written in the U.S. every month. For those of you forking out the dough for Plavix, the FDA just approved generic versions of the blood-thinning drug, which will now be available to you much cheaper as clopidogrel.

    Clopidogrel, the generic Plavix, is used to treat patients who have had a recent heart attack, but that’s not all. Here are a few ways clopidogrel helps us out:

    – It is used to stop heart attacks. See More

Copyright ©2018 GoodRx, Inc.

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.

In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.

Safe Pharmacy